Table 1 Demographic data of patients with and without ocular symptoms while on dupilumab.

From: Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae

 

Patients with ocular symptoms while on dupilumab

Patients without ocular symptoms

P value

Age ± SD (years)

38.5 ± 12.1

33.5 ± 13.4

0.194

Gender (F: female, M: male)

7 F, 7 M

5 F, 9 M

0.352

Race

12 Caucasians,

1 of Asian descent,

1 not recorded

11 Caucasians,

1 of Asian descent,

2 not recorded

0.355